Dr. Amer Burhan, MD, is a co-founder of Precision Cognitive and Neuropsychiatry Institute (PCNI), a forward-thinking organization devoted to the accessible and evidence-based application of mental health and neurocognitive technologies in mental health care. As a Geriatric and Interventional Psychiatrist, Dr. Burhan brings over 21 years of clinical expertise to his work, blending his roles as a medical expert, educator, researcher, and leader to drive transformative change in patient care.

A seasoned clinician-researcher, Dr. Burhan’s focus centers on treatment-resistant depression and the use of novel interventions, including brain stimulation and ketamine, to provide relief for this challenging condition. He is also recognized for his expertise in cognitive disorders, with a keen interest in exploring the intersections between treatment-resistant depression and cognitive health. In his research role, Dr. Burhan serves as the site Principal Investigator on several clinical trials examining intravenous ketamine as a therapeutic option for mental health disorders, alongside his active involvement in trials targeting cognitive conditions.

Dr. Burhan holds an Endowed Research Chair in Applied Mental Health and is an Associate Professor of Psychiatry at the University of Toronto. His commitment to innovation in mental health treatment is matched by his dedication to enhancing patient outcomes through rigorous research and compassionate care.